9989 — Shenzhen Hepalink Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapSuper Stock

Market Cap
HK$6.54bn
Enterprise Value
HK$7.12bn
Revenue
CNY5.28bn

Annual balance sheet for Shenzhen Hepalink Pharmaceutical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	CAS	CAS	CAS	CAS	CAS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	3,541	3,873	3,334	2,266	2,557
Net Total Accounts Receivable
Net Total Receivables	2,026	1,938	1,927	1,529	1,516
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	9,129	10,770	12,390	10,604	9,621
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2,571	2,537	2,477	2,634	2,648
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	19,026	19,108	20,816	19,203	17,344
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3,613	4,791	5,576	4,986	3,699
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	7,457	7,697	8,503	7,290	5,195
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	11,569	11,411	12,313	11,913	12,149
Total Liabilities & Shareholders' Equity	19,026	19,108	20,816	19,203	17,344
Total Common Shares Outstanding